# Joseph Imperato

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/joseph-imperato/

## Facts

| Field | Value |
| --- | --- |
| Citations | 85 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 5 |
| i10-index | 3 |
| Last Known Institution | IQVIA (United States) |
| OpenAlex ID | https://openalex.org/A5004903907 |
| ORCID iD | 0000-0003-1153-7367 |
| Works | 14 |

## Researcher papers

- [&lt;p&gt;Harnessing Real-World Data for Regulatory Use and Applying Innovative Applications&lt;/p&gt;](https://scholariq.org/papers/and-lt-p-and-gt-harnessing-real-world-data-for-regulatory-use-and-applying/)
- [New Strategies to Improve Patient Adherence to Medications for Noncommunicable Diseases During and After the COVID-19 Era Identified via a Literature Review](https://scholariq.org/papers/new-strategies-to-improve-patient-adherence-to-medications-for-noncommunicable/)
- [Harnessing real-world evidence to reduce the burden of noncommunicable disease: health information technology and innovation to generate insights](https://scholariq.org/papers/harnessing-real-world-evidence-to-reduce-the-burden-of-noncommunicable-disease/)
- [Clinical Practice Management of Primary Open-Angle Glaucoma in the United States: An Analysis of Real-World Evidence](https://scholariq.org/papers/clinical-practice-management-of-primary-open-angle-glaucoma-in-the-united-states/)
- [COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US](https://scholariq.org/papers/copd-exacerbations-before-and-during-covid-19-in-france-germany-italy-the-uk-and/)
- [Harnessing Real-World Data for Regulatory Use and Applying Innovative Applications](https://scholariq.org/papers/harnessing-real-world-data-for-regulatory-use-and-applying-innovative/)
- [Health-Care Resource Utilization and Treatment Patterns in Men with Erectile Dysfunction and Benign Prostatic Hyperplasia-Associated Lower Urinary Tract Symptoms in the United States: A Retrospective Database Study](https://scholariq.org/papers/health-care-resource-utilization-and-treatment-patterns-in-men-with-erectile/)
- [#1968 IgA nephropathy and impact of proteinuria and kidney function decline on healthcare resource utilisation among adults in the United Kingdom](https://scholariq.org/papers/1968-iga-nephropathy-and-impact-of-proteinuria-and-kidney-function-decline-on/)
- [CO167 Examining Real-World Utilization and Associated Clinical Outcomes of Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) in Patients With Atrial Fibrillation in Italy](https://scholariq.org/papers/co167-examining-real-world-utilization-and-associated-clinical-outcomes-of-non/)
- [Real-world use and clinical outcomes among patients with atrial fibrillation using low-dose edoxaban and apixaban in Italy](https://scholariq.org/papers/real-world-use-and-clinical-outcomes-among-patients-with-atrial-fibrillation/)
- [Health Care Resource Utilization and Associated Costs Across Proteinuria and Declining Kidney Function in Patients With IgA Nephropathy: A Retrospective Study in Three European Countries](https://scholariq.org/papers/health-care-resource-utilization-and-associated-costs-across-proteinuria-and/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Researcher university

- [IQVIA (United States)](https://scholariq.org/institutions/iqvia-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
